IRIS
PATRONE, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.704
AS - Asia 70
SA - Sud America 15
AF - Africa 1
Totale 23.790
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.704
CN - Cina 60
BR - Brasile 9
SG - Singapore 6
VN - Vietnam 4
EC - Ecuador 3
AR - Argentina 2
CO - Colombia 1
EG - Egitto 1
Totale 23.790
Salva come PNG Salva come JPEG
Città #
Genova 15.082
Genoa 5.087
Rapallo 2.204
Vado Ligure 1.289
Bordighera 42
Beijing 20
Guayaquil 2
Ho Chi Minh City 2
Bento Gonçalves 1
Bogotá 1
Cairo 1
Ceará-Mirim 1
Corumbá 1
Duque de Caxias 1
Haiphong 1
Hefei 1
Manta 1
Rio de Janeiro 1
San Juan 1
Santa Sylvina 1
Santana do Ipanema 1
Singapore 1
São Bernardo do Campo 1
São Paulo 1
Varginha 1
Totale 23.745
Salva come PNG Salva come JPEG
Nome #
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 225
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 220
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 218
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 216
APO866 activity in hematologic malignancies: a preclinical in vitro study. 204
Autophagy in blood cancers: biological role and therapeutic implications. 204
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 204
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 199
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 181
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 180
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 179
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 178
Anticancer vaccination strategies. 178
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 178
Ras-induced resistance to lapatinib is overcome by MEK inhibition 175
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 175
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 174
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 171
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 169
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 167
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 167
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 167
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 166
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 166
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 165
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 164
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 163
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 163
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 162
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 162
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 161
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 158
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 157
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 155
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 152
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 152
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 152
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 150
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 150
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 150
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 149
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 148
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 147
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 147
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 146
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 145
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 144
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 143
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 143
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 142
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 141
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 140
In vitro effects of synthetic chemotactic peptides on neutrophil function. 139
Autologous peripheral blood stem cells (PBSC) in breast cancer. 138
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 137
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 137
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 137
The use of dendritic cells in cancer immunotherapy. 137
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 136
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 135
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 134
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 134
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 134
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 133
[Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. 133
New insights into biology of chronic myeloid leukemia: implications in therapy. 133
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 132
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 131
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 131
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 131
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 130
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 128
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 128
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 127
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 126
Hyperimmunoglobulinemia E syndrome. 126
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 126
Stimulation of neutrophil locomotion by inosiplex. 125
Phagocytosis-dependent neutrophil-mediated extracellular cytotoxicity against different target cells. 124
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 123
Neutrophil functions in acne conglobata. 123
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 123
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. 123
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 123
The proteasome and its inhibitors in immune regulation and immune disorders. 122
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 122
Neutrophil chemotaxis: physiology and pathology. 120
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. 120
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 120
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 120
Defective neutrophil mobilization to skin chambers in cancer patients. 119
Ox erythrocyte cytotoxicity by phorbol myristate acetate-activated human neutrophils. 118
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 118
Target cell lysis mediated by concanavalin A-triggered human neutrophils. 116
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 115
Proteasome inhibitors: antitumor effects and beyond 115
Effector-target co-aggregation as a crucial step in the neutrophil-mediated tumour cell lysis. 114
[Semiquantitative evaluation of leukocyte acid phosphatase]. 114
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 114
Immunopathological studies on a case of Sweet's syndrome. 113
Totale 14.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.194
article - articoli 67.817
book - libri 0
conference - conferenze 408
curatela - curatele 0
other - altro 0
patent - brevetti 120
selected - selezionate 0
volume - volumi 849
Totale 138.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021963 0 0 0 77 80 130 76 106 130 116 145 103
2021/20222.402 57 182 172 256 176 144 128 536 78 243 109 321
2022/20232.651 270 195 18 290 437 490 12 199 462 12 241 25
2023/20241.256 44 159 23 148 99 268 43 140 54 21 64 193
2024/20253.235 109 270 95 213 454 272 296 592 87 135 306 406
2025/20261.567 731 150 281 405 0 0 0 0 0 0 0 0
Totale 23.890